Schonfeld Strategic Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
|
|||||
|
2025
Q1 | $832K | Sell |
|
|||||
|
2024
Q4 | $29.9M | Buy |
|
|||||
|
2024
Q3 | $7.66M | Sell |
|
|||||
|
2024
Q2 | $10.7M | Sell |
|
|||||
|
2024
Q1 | $35.2M | Buy |
|
|||||
|
2023
Q4 | $374K | Sell |
|
|||||
|
2023
Q3 | $7.46M | Buy |
|
|||||
|
2023
Q2 | $468K | Sell |
|
|||||
|
2023
Q1 | $3.05M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $6.73M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.09M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $3.22M | Buy |
|
|||||
|
2021
Q1 | $1.14M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $5.34M | Buy |
|
|||||
|
2019
Q1 | $5.86M | Buy |
|
|||||
|
2018
Q4 | $1.09M | Sell |
|
|||||
|
2018
Q3 | $5.82M | Hold |
|
|||||
|
2018
Q2 | $6.55M | Buy |
|
|||||
|
2018
Q1 | $1.79M | Sell |
|
|||||
|
2017
Q4 | $2.36M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.74M | Buy |
|